Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Sep 9, 2025
- Accession no.
- 0000950170-25-113874
- Filed
- Sep 9, 2025
- Trade date
- Sep 8, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $200.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2025 | Common Stock | PPurchaseAcquired | +800 | $127.20 | +$101,760 | 47,437 | Direct | |
| Sep 8, 2025 | Common Stock | PPurchaseAcquired | +287 | $127.30 | +$36,535.1 | 47,724 | Direct | |
| Sep 8, 2025 | Common Stock | PPurchaseAcquired | +488 | $127.40 | +$62,171.2 | 48,212 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.